As of Dec 08
| -0.15 / -3.16%|
The 2 analysts offering 12-month price forecasts for InVivo Therapeutics Holdings Corp have a median target of 16.63, with a high estimate of 23.25 and a low estimate of 10.00. The median estimate represents a +261.41% increase from the last price of 4.60.
The current consensus among 2 polled investment analysts is to Buy stock in InVivo Therapeutics Holdings Corp. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.